Indian FDA pushes for broader generic-drug use

04/21/2013 | Times of India, The

A state Food and Drug Administration commissioner in India denied that the bio-availability of generic drugs is doubtful, in spite of claims to the contrary made by doctors and chemists. "Bio-availability" is a term used for the amount of a drug that reaches its target. "These are excuses to deny people their right to get medicines at rational prices," said Commissioner Mahesh Zagade, who urged the national government to require that physicians add a line to prescriptions noting that generic or other cheaper versions are available.

View Full Article in:

Times of India, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID